feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Earthquake swarm rattles San Ramon

trending

DR Congo faces Benin

trending

49ers activate Yetur Gross-Matos

trending

Curry leads Warriors past Magic

trending

George Kittle ankle injury

trending

Cade Cunningham jersey retired

trending

Kraken beat Anaheim Ducks

trending

McConaughey returns to late-night TV

trending

Pat Spencer All-Value Team

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / World First: Gene Therapy Eradicates Incurable Leukemia in Teen

World First: Gene Therapy Eradicates Incurable Leukemia in Teen

9 Dec

•

Summary

  • A 16-year-old is the first patient globally to receive new gene therapy.
  • The groundbreaking treatment successfully cleared aggressive leukemia.
  • The patient has been cancer-free for three years following the therapy.
World First: Gene Therapy Eradicates Incurable Leukemia in Teen

A remarkable medical breakthrough has seen a 16-year-old girl declared free of an incurable blood cancer. Alyssa Tapley received a revolutionary new gene therapy three years ago, making her the first patient globally to undergo this experimental treatment for aggressive leukemia.

The intensive treatment, which included two bone marrow transplants and the gene therapy, was administered at Great Ormond Street Hospital. This pioneering approach has proven successful, leading to Alyssa remaining cancer-free since the procedure, a significant milestone in cancer research and patient care.

Her story offers a beacon of hope for countless individuals facing similar diagnoses. The success of this gene therapy marks a pivotal moment, potentially paving the way for new, effective treatments for previously untreatable blood cancers.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
It is a novel gene therapy used to treat aggressive and previously incurable blood cancers, with a 16-year-old being the first recipient.
Alyssa Tapley has been cancer-free for three years following her groundbreaking gene therapy treatment.
The pioneering gene therapy was administered at Great Ormond Street Hospital and University College London.

Read more news on

Healthside-arrow

You may also like

Sister's Love: A Double Life-Saving Christmas Miracle

1 day ago • 10 reads

article image

Trainer's Daughter Beats Leukemia

14 Dec • 65 reads

article image

TV Star's Agonizing 'Suicide Disease' Battle

14 Dec • 59 reads

article image

Kardashian Stem Cell Secret: Kylie Follows Kim's Pain Relief

5 Dec • 90 reads

article image

Family's Genetic Curse: 80% Cancer Risk Unveiled

2 Dec • 112 reads

article image